Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Subscriber list
The list of groups and individuals signed up to purchase a publication on a regular basis. Subscribers are customers, members, or contacts who grant permission to a third party to send material via email or print publications to them.
See also:
Readership
Database marketing
Related terms
Ad impression , Segmentation strategies, Banner Ad., Consumer, Market segmentation, Models (or marketing models), Market share, Maintenance strategy, Brand, Direct-to-consumer (DTC), Ladder of loyalty, Export marketing, Infiltration marketing, Investigational new drug (IND), Social marketing,
COVID-19 Updates and Daily News
Featured jobs
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
-
Head of Copy
-
£ competitive
- Pfizer CEO announces plans to launch Omicron-specific COVID-19 vaccine
- Pfizer expands access to lipid nanoparticle technology in new agreement with Acuitas Therapeutics
- Biogen’s Alzheimer’s treatment Aduhelm limited to clinical trial participants in the US
- AstraZeneca's Enhertu receives FDA grant for priority review
- AstraZeneca’s Vaxzevria trial provides further support for protection against COVID-19 variants
- BioNTech and InstaDeep collaboration develops SARS-CoV-2 Early Warning System
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- Almirall and IRB Barcelona announce new research collaboration
- 6 critical success factors for flawless execution of a rapid first commercial launch
- Meet Innovative Trials at SCOPE 2022
- We let your whole self shine
- EMA proposes EU clinical trial reforms
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- Pfizer CEO announces plans to launch Omicron-specific COVID-19 vaccine
- Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
- EU cross-border healthcare
- The true meaning of market access?
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
PMHub
Say Communications
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...
